CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
angioplasty, transluminal, percutaneous coronary +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000465
NCT00000465Phase 3Completed
CompareCT.gov

Emory Angioplasty Versus Surgery Trial (EAST)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Feb 18, 2016

In Brief

A Phase 3 clinical trial evaluating angioplasty, transluminal, percutaneous coronary and coronary artery bypass for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To compare the efficacy of coronary artery bypass graft (CABG) surgery with percutaneous transluminal coronary angioplasty (PTCA) in patients with multiple vessel coronary heart disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Ischemia
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJun 1, 1987
Study CompletionAug 1, 1998
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

angioplasty, transluminal, percutaneous coronaryprocedure

coronary artery bypassprocedure